Research & KnowledgeEvent: September 5, 2026
Pfizer published a study by Young et al. in collaboration with Megadalton Solutions showing how charge detection mass spectrometry (CDMS) can extend intact-mass analysis to large mRNA constructs.
Published
Signal category
Research & Knowledge
Quote
“A new study from Young et al., a collaboration between Megadalton Solutions and Pfizer shows how charge detection mass spectrometry (CDMS) can extend intact-mass analysis to large mRNA constructs.”
— Mark Hilliard|Pfizer team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- New York, US
- Company size
- 109,247 employees
We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines